IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 289 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $572,000 | -5.5% | 13,725 | 0.0% | 0.02% | 0.0% |
| Q1 2018 | $605,000 | -50.4% | 13,725 | -43.3% | 0.02% | -48.3% |
| Q4 2017 | $1,219,000 | -2.8% | 24,225 | -2.0% | 0.03% | -6.5% |
| Q3 2017 | $1,254,000 | -4.0% | 24,725 | -3.7% | 0.03% | -3.1% |
| Q2 2017 | $1,306,000 | +24.4% | 25,675 | -1.7% | 0.03% | +23.1% |
| Q1 2017 | $1,050,000 | -27.1% | 26,125 | -13.3% | 0.03% | -31.6% |
| Q4 2016 | $1,441,000 | +30.5% | 30,125 | 0.0% | 0.04% | +31.0% |
| Q3 2016 | $1,104,000 | +57.3% | 30,125 | 0.0% | 0.03% | +52.6% |
| Q2 2016 | $702,000 | -55.1% | 30,125 | -22.0% | 0.02% | -34.5% |
| Q1 2016 | $1,564,000 | -35.5% | 38,625 | -1.3% | 0.03% | -35.6% |
| Q4 2015 | $2,423,000 | – | 39,125 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |